Veterinary Vaccines Market Size, Share, and Outlook, H2-2025 Report- By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, Others), By Disease (Porcine Diseases, Poultry Diseases, Livestock Disea
Description
Veterinary Vaccines Market Outlook
The global Veterinary Vaccines Market Size is valued at $9.2 Billion in 2025 and is forecast to reach $14.2 Billion in 2032 at a CAGR of 6.4%.
The Veterinary Vaccines Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Veterinary Vaccines Market segments across 22 countries from 2021 to 2032. Key segments covered include By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, Others), By Disease (Porcine Diseases, Poultry Diseases, Livestock Diseases, Companion Animal Diseases, Aquaculture Diseases), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Others), By Route of Administration (Injection Vaccines, Oral Vaccines, Intranasal/Spray Vaccines), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Veterinary Vaccines Market Insights, 2025
The veterinary vaccines market is witnessing strong growth due to rising awareness of zoonotic diseases and preventive healthcare for livestock and companion animals. Recent developments include mRNA-based vaccines, recombinant vaccines, and multivalent formulations that target multiple pathogens simultaneously. Companies are focusing on improving vaccine stability, ease of administration, and enhanced immune responses. Growth is driven by increasing pet ownership, livestock health management needs, and stringent government regulations for disease prevention. Research emphasizes rapid vaccine development platforms, cold-chain management solutions, and field-deployable delivery systems. Emerging trends include oral vaccines, nanoparticle-based adjuvants, and integration with digital tracking for immunization compliance. Regulatory approvals and government initiatives in disease control are facilitating market expansion. Overall, the market prioritizes innovation, safety, and improved herd and companion animal immunity.
Five Trends Shaping the Global Veterinary Vaccines Market in 2025 and Beyond
The global Veterinary Vaccines Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Veterinary Vaccines Industry?
The Veterinary Vaccines Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Veterinary Vaccines Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Veterinary Vaccines Market Segment Insights
The Veterinary Vaccines Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, Others), By Disease (Porcine Diseases, Poultry Diseases, Livestock Diseases, Companion Animal Diseases, Aquaculture Diseases), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Others), By Route of Administration (Injection Vaccines, Oral Vaccines, Intranasal/Spray Vaccines), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Veterinary Vaccines Industry Value Chain
The chapter identifies potential companies and their operations across the global Veterinary Vaccines Industry ecosystem. It assists decision-makers in evaluating global Veterinary Vaccines Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Veterinary Vaccines Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Veterinary Vaccines Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Veterinary Vaccines Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Veterinary Vaccines Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Veterinary Vaccines Market.
Europe Veterinary Vaccines Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Veterinary Vaccines Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Veterinary Vaccines Industry competitiveness. The report analyses the key Veterinary Vaccines Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Veterinary Vaccines Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Veterinary Vaccines Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Veterinary Vaccines Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Veterinary Vaccines Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Veterinary Vaccines Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Veterinary Vaccines Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Aptimmune Biologics Inc, Biogénesis Bagó S.A., Biovac Biotech, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Ltd, Ceva Santé Animale, China Animal Husbandry Group, Elanco Animal Health (Eli Lilly and Company), Endovac Animal Health, Hester Biosciences Ltd, HIPRA - Laboratorios Hipra S.A., Indian Immunologicals Ltd, Intas Pharmaceuticals Ltd, Jinyu Bio-technology Co. Ltd, Laboratoire LCV, Merck & Co. Inc, Neogen Corp, Ourofino Saúde Animal Ltda., Phibro Animal Health Corp, Tianjin Ringpu Bio-Technology Co. Ltd, Torigen Pharmaceuticals Inc, Vaxxinova International BV, VEROVACCiNES GmbH, Virbac SA, Zoetis Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Veterinary Vaccines Market Scope
Leading Segments
By Type
Porcine Vaccines
Poultry Vaccines
Livestock VaccinesBovine Vaccines Small Ruminant Vaccines
Companion Animal VaccinesCanine Vaccines Feline Vaccines
Aquaculture Vaccines
Others
By Disease
Porcine Diseases
Poultry Diseases
Livestock Diseases
Companion Animal Diseases
Aquaculture Diseases
By Technology
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others
By Route of Administration
Injection Vaccines
Oral Vaccines
Intranasal/Spray Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Others
Leading Companies
Aptimmune Biologics Inc
Biogénesis Bagó S.A.
Biovac Biotech
Boehringer Ingelheim International GmbH
Brilliant Bio Pharma Ltd
Ceva Santé Animale
China Animal Husbandry Group
Elanco Animal Health (Eli Lilly and Company)
Endovac Animal Health
Hester Biosciences Ltd
HIPRA - Laboratorios Hipra S.A.
Indian Immunologicals Ltd
Intas Pharmaceuticals Ltd
Jinyu Bio-technology Co. Ltd
Laboratoire LCV
Merck & Co. Inc
Neogen Corp
Ourofino Saúde Animal Ltda.
Phibro Animal Health Corp
Tianjin Ringpu Bio-Technology Co. Ltd
Torigen Pharmaceuticals Inc
Vaxxinova International BV
VEROVACCiNES GmbH
Virbac SA
Zoetis Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Veterinary Vaccines Market Size is valued at $9.2 Billion in 2025 and is forecast to reach $14.2 Billion in 2032 at a CAGR of 6.4%.
The Veterinary Vaccines Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Veterinary Vaccines Market segments across 22 countries from 2021 to 2032. Key segments covered include By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, Others), By Disease (Porcine Diseases, Poultry Diseases, Livestock Diseases, Companion Animal Diseases, Aquaculture Diseases), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Others), By Route of Administration (Injection Vaccines, Oral Vaccines, Intranasal/Spray Vaccines), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Veterinary Vaccines Market Insights, 2025
The veterinary vaccines market is witnessing strong growth due to rising awareness of zoonotic diseases and preventive healthcare for livestock and companion animals. Recent developments include mRNA-based vaccines, recombinant vaccines, and multivalent formulations that target multiple pathogens simultaneously. Companies are focusing on improving vaccine stability, ease of administration, and enhanced immune responses. Growth is driven by increasing pet ownership, livestock health management needs, and stringent government regulations for disease prevention. Research emphasizes rapid vaccine development platforms, cold-chain management solutions, and field-deployable delivery systems. Emerging trends include oral vaccines, nanoparticle-based adjuvants, and integration with digital tracking for immunization compliance. Regulatory approvals and government initiatives in disease control are facilitating market expansion. Overall, the market prioritizes innovation, safety, and improved herd and companion animal immunity.
Five Trends Shaping the Global Veterinary Vaccines Market in 2025 and Beyond
The global Veterinary Vaccines Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Veterinary Vaccines Industry?
The Veterinary Vaccines Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Veterinary Vaccines Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Veterinary Vaccines Market Segment Insights
The Veterinary Vaccines Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines, Others), By Disease (Porcine Diseases, Poultry Diseases, Livestock Diseases, Companion Animal Diseases, Aquaculture Diseases), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Others), By Route of Administration (Injection Vaccines, Oral Vaccines, Intranasal/Spray Vaccines), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Veterinary Vaccines Industry Value Chain
The chapter identifies potential companies and their operations across the global Veterinary Vaccines Industry ecosystem. It assists decision-makers in evaluating global Veterinary Vaccines Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Veterinary Vaccines Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Veterinary Vaccines Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Veterinary Vaccines Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Veterinary Vaccines Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Veterinary Vaccines Market.
Europe Veterinary Vaccines Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Veterinary Vaccines Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Veterinary Vaccines Industry competitiveness. The report analyses the key Veterinary Vaccines Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Veterinary Vaccines Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Veterinary Vaccines Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Veterinary Vaccines Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Veterinary Vaccines Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Veterinary Vaccines Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Veterinary Vaccines Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Aptimmune Biologics Inc, Biogénesis Bagó S.A., Biovac Biotech, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Ltd, Ceva Santé Animale, China Animal Husbandry Group, Elanco Animal Health (Eli Lilly and Company), Endovac Animal Health, Hester Biosciences Ltd, HIPRA - Laboratorios Hipra S.A., Indian Immunologicals Ltd, Intas Pharmaceuticals Ltd, Jinyu Bio-technology Co. Ltd, Laboratoire LCV, Merck & Co. Inc, Neogen Corp, Ourofino Saúde Animal Ltda., Phibro Animal Health Corp, Tianjin Ringpu Bio-Technology Co. Ltd, Torigen Pharmaceuticals Inc, Vaxxinova International BV, VEROVACCiNES GmbH, Virbac SA, Zoetis Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Veterinary Vaccines Market Scope
Leading Segments
By Type
Porcine Vaccines
Poultry Vaccines
Livestock Vaccines
Companion Animal Vaccines
Aquaculture Vaccines
Others
By Disease
Porcine Diseases
Poultry Diseases
Livestock Diseases
Companion Animal Diseases
Aquaculture Diseases
By Technology
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others
By Route of Administration
Injection Vaccines
Oral Vaccines
Intranasal/Spray Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Others
Leading Companies
Aptimmune Biologics Inc
Biogénesis Bagó S.A.
Biovac Biotech
Boehringer Ingelheim International GmbH
Brilliant Bio Pharma Ltd
Ceva Santé Animale
China Animal Husbandry Group
Elanco Animal Health (Eli Lilly and Company)
Endovac Animal Health
Hester Biosciences Ltd
HIPRA - Laboratorios Hipra S.A.
Indian Immunologicals Ltd
Intas Pharmaceuticals Ltd
Jinyu Bio-technology Co. Ltd
Laboratoire LCV
Merck & Co. Inc
Neogen Corp
Ourofino Saúde Animal Ltda.
Phibro Animal Health Corp
Tianjin Ringpu Bio-Technology Co. Ltd
Torigen Pharmaceuticals Inc
Vaxxinova International BV
VEROVACCiNES GmbH
Virbac SA
Zoetis Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
200 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Veterinary Vaccines Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Veterinary Vaccines Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Veterinary Vaccines Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Veterinary Vaccines Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Veterinary Vaccines Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Type
- Porcine Vaccines
- Poultry Vaccines
- Livestock Vaccines
- -Bovine Vaccines
- -Small Ruminant Vaccines
- Companion Animal Vaccines
- -Canine Vaccines
- -Feline Vaccines
- Aquaculture Vaccines
- Others
- By Disease
- Porcine Diseases
- Poultry Diseases
- Livestock Diseases
- Companion Animal Diseases
- Aquaculture Diseases
- By Technology
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Others
- By Route of Administration
- Injection Vaccines
- Oral Vaccines
- Intranasal/Spray Vaccines
- By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Others
- 6. Global Veterinary Vaccines Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Veterinary Vaccines Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Veterinary Vaccines Market Trends and Growth Opportunities
- 6.2.1 North America Veterinary Vaccines Market Outlook by Type
- 6.2.2 North America Veterinary Vaccines Market Outlook by Application
- 6.3 North America Veterinary Vaccines Market Outlook by Country
- 6.3.1 The US Veterinary Vaccines Market Outlook, 2021- 2032
- 6.3.2 Canada Veterinary Vaccines Market Outlook, 2021- 2032
- 6.3.3 Mexico Veterinary Vaccines Market Outlook, 2021- 2032
- 7. Europe Veterinary Vaccines Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Veterinary Vaccines Market Trends and Growth Opportunities
- 7.2.1 Europe Veterinary Vaccines Market Outlook by Type
- 7.2.2 Europe Veterinary Vaccines Market Outlook by Application
- 7.3 Europe Veterinary Vaccines Market Outlook by Country
- 7.3.2 Germany Veterinary Vaccines Market Outlook, 2021- 2032
- 7.3.3 France Veterinary Vaccines Market Outlook, 2021- 2032
- 7.3.4 The UK Veterinary Vaccines Market Outlook, 2021- 2032
- 7.3.5 Spain Veterinary Vaccines Market Outlook, 2021- 2032
- 7.3.6 Italy Veterinary Vaccines Market Outlook, 2021- 2032
- 7.3.7 Russia Veterinary Vaccines Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Veterinary Vaccines Market Outlook, 2021- 2032
- 8. Asia Pacific Veterinary Vaccines Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Veterinary Vaccines Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Veterinary Vaccines Market Outlook by Type
- 8.2.2 Asia Pacific Veterinary Vaccines Market Outlook by Application
- 8.3 Asia Pacific Veterinary Vaccines Market Outlook by Country
- 8.3.1 China Veterinary Vaccines Market Outlook, 2021- 2032
- 8.3.2 India Veterinary Vaccines Market Outlook, 2021- 2032
- 8.3.3 Japan Veterinary Vaccines Market Outlook, 2021- 2032
- 8.3.4 South Korea Veterinary Vaccines Market Outlook, 2021- 2032
- 8.3.5 Australia Veterinary Vaccines Market Outlook, 2021- 2032
- 8.3.6 South East Asia Veterinary Vaccines Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Veterinary Vaccines Market Outlook, 2021- 2032
- 9. South America Veterinary Vaccines Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Veterinary Vaccines Market Trends and Growth Opportunities
- 9.2.1 South America Veterinary Vaccines Market Outlook by Type
- 9.2.2 South America Veterinary Vaccines Market Outlook by Application
- 9.3 South America Veterinary Vaccines Market Outlook by Country
- 9.3.1 Brazil Veterinary Vaccines Market Outlook, 2021- 2032
- 9.3.2 Argentina Veterinary Vaccines Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Veterinary Vaccines Market Outlook, 2021- 2032
- 10. Middle East and Africa Veterinary Vaccines Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Veterinary Vaccines Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Veterinary Vaccines Market Outlook by Type
- 10.2.2 Middle East and Africa Veterinary Vaccines Market Outlook by Application
- 10.3 Middle East and Africa Veterinary Vaccines Market Outlook by Country
- 10.3.1 Saudi Arabia Veterinary Vaccines Market Outlook, 2021- 2032
- 10.3.2 The UAE Veterinary Vaccines Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Veterinary Vaccines Market Outlook, 2021- 2032
- 10.3.4 South Africa Veterinary Vaccines Market Outlook, 2021- 2032
- 10.3.5 Egypt Veterinary Vaccines Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Veterinary Vaccines Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Aptimmune Biologics Inc
- Biogénesis Bagó S.A.
- Biovac Biotech
- Boehringer Ingelheim International GmbH
- Brilliant Bio Pharma Ltd
- Ceva Santé Animale
- China Animal Husbandry Group
- Elanco Animal Health (Eli Lilly and Company)
- Endovac Animal Health
- Hester Biosciences Ltd
- HIPRA - Laboratorios Hipra S.A.
- Indian Immunologicals Ltd
- Intas Pharmaceuticals Ltd
- Jinyu Bio-technology Co. Ltd
- Laboratoire LCV
- Merck & Co. Inc
- Neogen Corp
- Ourofino Saúde Animal Ltda.
- Phibro Animal Health Corp
- Tianjin Ringpu Bio-Technology Co. Ltd
- Torigen Pharmaceuticals Inc
- Vaxxinova International BV
- VEROVACCiNES GmbH
- Virbac SA
- Zoetis Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
